Benchmarking large language models on genomic variants reveals their potential in precision oncology applications.
Interpreting genomic variants from cancer sequencing data is a critical yet complex task in precision oncology. With advances in large language models (LLMs), there is increasing interest in leveraging their capacity for variant classification. This study benchmarks three state-of-the-art LLMs - GPT-4o, LLaMA 3, and Qwen 2.5 - on curated cancer variant databases to assess their utility in clinical genomic interpretation.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: